drugset / Trial / NCT02276560
Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.
Timeline
- Start
- 2015-01
- Primary completion
- 2016-06
- Completion
- 2016-06
Outcome
Outcome not reported
Stopped (Business): “This study was terminated due to lack of funding.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | Nab-paclitaxel | Small molecule | 125 mg/m2 | — |
| Subject | Pemetrexed | Small molecule | 500 mg/m2 | — |